Andreas Stadlbauer1, Max Zimmermann1, Karl Rössler1, Stefan Oberndorfer2, Arnd Dörfler3, Michael Buchfelder1, and Gertraud Heinz4
1Department of Neurosurgery, University of Erlangen, Erlangen, Germany, 2Department of Neurology, University Clinic of St. Pölten, St. Pölten, Austria, 3Department of Neuroradiology, University of Erlangen, Erlangen, Germany, 4Department of Radiology, University Clinic of St. Pölten, St. Pölten, Austria
Synopsis
Knowledge about the tumor microvasculature is
important for monitoring of disease progression and treatment response. Forty-six
patients with known or suspected brain tumors were examined using the vascular
architecture mapping (VAM) technique.
ΔR2,GE versus
(ΔR2,SE)3/2 diagrams were
evaluated with new versions of microvessel radius (RU) and density
(NU), which showed increased levels of heterogeneous structures in
glioblastoma and meningioma. Three new imaging biomarkers were introduced: Microvessel
type indicator (MTI), which allowed differentiation between supplying
arterial and draining venous microvasculature. Vascular
induced peak shift (VIPS), which is more sensitive to early angiogenic activity. Curvature
was increased in peritumoral vasogenic edema.Purpose
Knowledge of the topological and structural
heterogeneity of tumor microvasculature is important for monitoring of disease
progression and treatment response [1]. A vessel caliber and type dependent
temporal shift between the signal of gradient-echo (GE) and spin-echo (SE) dynamic
susceptibility-weighted (DSC) MRI has been described recently [1]. This
phenomenon forms the basis for the vascular architecture mapping (VAM)
technique. In this study we introduce new MR imaging biomarkers for the assessment
of vascular pathologies in gliomas using VAM.
Methods
Forty-six patients with known or suspected brain tumors
(7 low-grade glioma, 12 glioma WHO° III, 25 glioblastoma, and 2 meningioma) were
examined at 3 Tesla (Trio, Siemens) using the VAM technique. We used a dual
contrast agent injection approach to obtain GE- and SE-EPI DSC perfusion MRI
data [2]. To minimize patient motions and differences in the time to first-pass
peak between the two DSC examinations we employed the following strategies: i) proper fixation of the patient’s
head and clear, repeated patient instructions before and during the MRI
examinations, and ii) a peripheral
pulse unit (PPU) fitted to a finger of the patient to monitor heart rate and
cardiac cycle. Special attention was paid to perform the two injections at the
same heart rate and exactly at the same phase of the cardiac cycle (at PPU’s peak
systole signal). Geometric parameters and measurement parameters were identical
for the GE- and SE-EPI DSC perfusion MRI sequences (TR: 1740 ms; in-plane
resolution: 1.8 x 1.8 mm, slice thickness: 4 mm; 29 slices; GRAPPA: 2; and 60
dynamic measurements) except for TE (33 ms for SE-EPI and 22 ms for GE-EPI).
Both DSC perfusion MRI examinations were performed with administration of 0.1
mmol/kg-bodyweight gadoterate meglumine (Dotarem, Guerbet) at a rate of 4 ml/s
with utmost attention to the injection time (see above). Custom-made in-house
MatLab software was used for calculation of
ΔR
2,GE versus
(ΔR
2,SE)
3/2 diagrams, which we termed vascular hysteresis
loops (VHLs, Fig. 1B and C), for each brain voxel. The index Q=ΔR
2,GE/(ΔR
2,SE)
3/2 was calculated. VHLs were evaluated with new versions
of the known parameters microvessel radius (R
U) and density (N
U) [3] which were adapted
to the temporal shift
phenomenon (Fig. 2A) as well as with three new imaging biomarkers: i) microvessel type indicator (MTI) as
the signed hysteresis area calculated from the difference between the areas
under the ascending and the descending brunch of the VHL (Fig. 2B), ii) vascular
induced peak shift (VIPS) as the time shift between the peak signals of SE- and
GE-EPI perfusion (Fig. 2C), and iii) the
curvature (Curv) of the long-axis of the VHL fitted with a quadratic polynomial
(Fig. 2D).
Results and
Discussion
Maps of R
U
and N
U showed increased levels of heterogeneous structures ranging
from mild to severe in glioblastoma and meningioma. Areas with severely
increased microvessel density NU were associated mildly increased to
normal microvessel radius RU and vice versa, i.e. maps of RU
and NU provided complementary and inversely correlated information.
Changes in RU and NU were found to be more moderately increased
in glioma WHO° III compared to glioblastoma, and were undetectable in low-grade
glioma. In accordance with Emblem et al. [1] and Xu et al. [4], VHLs transverse
in the counterclockwise direction if the vascular system contains venule- and
capillary-like vessel components [1], i.e. in case of more relative venous
blood volume [4]. Whereas, VHLs transverse in clockwise direction if vascular
system consist of arterioles and capillaries [1], i.e. in case of more relative
arterial blood volume [4]. A counterclockwise VHL-direction was associated with
negative MTI and VIPS values and a clockwise VHL-direction with positive MTI
and VIPS values, respectively. Maps of MTI allowed
differentiation between supplying arterial (areas with warm colors in Figs. 2B, 3C, 4C, 5C) and draining
venous microvasculature (areas with cool colors in Figs. 2B, 3C, 4C, 5C) within high-grade glioma and meningioma. VIPS
provided additional information about microvessel type at the tumor
periphery which is partly complementary to MTI.
Presumably, VIPS is more sensitive to early angiogenic activity. The changes in
MTI and VIPS in combination extended the contrast-enhancing tumor areas.
Interestingly, Curv was decreased in tumor but increased in peritumoral
vasogenic edema, which might be related to changes in the microvascular architecture
due to a breakdown of the tight endothelial junctions that make up the
blood-brain barrier.
Conclusions
These new MR imaging biomarkers provide insights
into the complexity and heterogeneity of vascular changes in brain tumors.
However, investigations in more well-defined patient populations and
histological validations are required.
Acknowledgements
No acknowledgement found.References
1. Emblem KE, Mouridsen K, Bjornerud A, et al. (2013)
Vessel architectural imaging identifies cancer patient responders to
anti-angiogenic therapy. Nat Med 19:1178–1183.
2. Hsu YY, Yang WS, Lim KE,
et al. (2009) Vessel Size Imaging
Using Dual Contrast Agent Injections. J Magn Reson Imaging 30:1078–1084.
3. Jensen JH, Lu H, and
Inglese M (2006) Microvessel Density Estimation in the Human Brain by Means of
Dynamic Contrast-Enhanced Echo-Planar Imaging. Magn Reson Med 56:1145–1150.
4. Xu C, Kiselev VG, Möller HE, Fiebach JB (2013)
Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic
susceptibility contrast imaging. Magn Reson Med 69:981–991.